CSPG5 (chondroitin sulfate proteoglycan 5) is an immune-related gene that functions as a growth and differentiation factor with roles in multiple cellular processes. In the nervous system, CSPG5 is implicated in cognitive function, with expression in the hypothalamus associated with digit symbol substitution test performance in genome-wide association studies 1. The gene shows altered expression during neuroinflammation, being downregulated in the cerebellum during experimental autoimmune encephalomyelitis alongside changes in chondroitin sulfate metabolism 2. CSPG5 plays a significant role in epithelial-mesenchymal transition (EMT), promoting cell migration and motility in lens epithelial cells during steroid-induced cataract formation 3 and in breast cancer cells where it contributes to a more aggressive phenotype 4. The gene serves as a prognostic biomarker in multiple cancers, being incorporated into immune-related risk signatures for epithelial ovarian carcinoma 56 and hepatocellular carcinoma 7. Additionally, CSPG5 polymorphisms are associated with kynurenine/tryptophan ratio regulation in HIV-infected patients, potentially linking it to immune system regulation and mortality risk 8. These findings establish CSPG5 as a multifunctional protein involved in neurological processes, cancer progression, and immune regulation.